TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: net adverse clinical events
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of women with successful fistula closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: efficiency of the locomotor mechanism
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: improved preventive foot care behaviour
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decreased prevalence of foot risk factors for ulceration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Discrepant results between central and local laboratory results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Treatment tolerance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stromal Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endothelial AUC0-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aqueous AUC0-2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of VAP (Ventilator-Associated Pneumonia)
Endpoint domain: Adverse events/effects
Primary endpoint: Tooth whitening effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite executive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical progression to MCI
Endpoint domain: Mortality/survival
Primary endpoint: Total Body Bone Mineral Density (BMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory depression (arterial oxyhaemoglobin saturation <90%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Severe hypoglycaemia
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of LA thrombi
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: KMI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MENQOL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: V˙E (ventilation rate)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Dyspnea
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean daily cry or fuss time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Interleukin-6 production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Proliferating stimulated CD4+ T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: 25-hydroxyvitamin D3 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attitudes toward SSE
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-efficacy beliefs in the ability to perform SSE
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Comfort with having someone help with SSE
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean number of flushes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in number and severity of flushes score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Well-being measurements
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: recurrent Clostridium difficile infection (rCDI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Personal changes to improve health
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increased awareness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Motivation from financial incentives
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cost-effectiveness of telemonitoring vs usual monitoring
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Suicide completion
Endpoint domain: Mortality/survival
Primary endpoint: Rates of clinical transfusion reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Laboratory abnormalities
Endpoint domain: Adverse events/effects
Primary endpoint: Total FIM score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Informed choice achievement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: median progression free survival (PFS)
Endpoint domain: Mortality/survival
Primary endpoint: View of the glottis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean Percentage Error (MPE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of pregnancies with MPE < 10%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of pregnancies with MPE < 5%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Any skin abnormalities/lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Area under the concentration-time curve (AUC(tau)) of nelfinavir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum observed plasma concentration (C(max)) of nelfinavir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum observed plasma concentration (C(min)) of nelfinavir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SF-12 MCS improvement
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Wasting (WAZ < -2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Stunting (LAZ < -2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Underweight (WLZ < -2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Anxiety levels post-abortion
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of dislocation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Serum level of IgE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum level of sICAM‐1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum level of IL‐4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Serum level of MMP‐9
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Client satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Superior smear layer removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative incidence rate of breast cancer-related lymphoedema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Lymphatic system outcomes
Primary endpoint: Total cholesterol change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive weight gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of infection episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Left internal mammary artery blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: maximum tolerated dose of levamisole
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: toxicity (nausea, vomiting, stomatitis, thrombocytopenia, granulocytopenia, diarrhea)
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of vaginal epithelial abnormalities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Levels of Calcium (Ca)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Levels of Phosphorus (P)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Characteristics of normal sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Actual graft survival at 2 years
Endpoint domain: Mortality/survival
Primary endpoint: Measured GFR at 1 year
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Breastfeeding prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Ratio of dental plaque removal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intake of dietary carotenoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: percentage of saturated fatty acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: ratio of long-chain n-6 to n-3 polyunsaturated fatty acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: MICA scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: RIBS scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SCILO (knowledge) scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Cumulative incidence of HIV infection
Endpoint domain: Mortality/survival
Primary endpoint: Patient satisfaction with test results communication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient satisfaction with information regarding medical treatments and conditions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Lung macrophage alpha-carotene concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Plasma concentrations of carotenoids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: urinary 11-DTB2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: OSDI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: meibum quality grades
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: expressibility grades
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to all-cause treatment failure
Endpoint domain: Mortality/survival
Primary endpoint: time to treatment failure related to heart disease
Endpoint domain: Mortality/survival
Primary endpoint: Bayley Mental Development Index scores at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac enlargement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Pulmonary artery enlargement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction of sleep bruxism (SB)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: altered aspects of smoking behavior
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCOverttmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean decrease in operating time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average cost of surgery
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Mean performance on the Four Alternative Auditory Feature test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sound quality ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall personal preference for the new hearing aid
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Serum glucose level variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum lactic acid level variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Volume of medication administered
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: nRBC count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Incidence of moderate-to-severe CRBD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: serum calcitonin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: onset of sensory and motor block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tourniquet pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: unpleasantness scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: loss of thermosensory function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: HIV-1-specific T-cell responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: persistent virus (total CD4 T cells viral DNA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: time to rebound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduction of diabetes-related distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: improvement of depressive symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: cerebral tissue oxygenation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: inotrope score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial profile improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood tryptase levels reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Cleveland Clinic Florida Fecal Incontinence score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fecal Incontinence Quality of Life scales
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Circulating T (CD4) cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: NK lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Episodes of hypoxia
Endpoint domain: Adverse events/effects
Primary endpoint: Crystalloid fluid volume required
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fluid creep incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Time to myocardial contrast wash-in of the infarcted segment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: High level of dependency in residents with stroke
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resource utilization costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Reduction in excretion of 8-iso-PGF2alpha
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of eating carrot-flavored cereal
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Facial expressions of distaste
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of subacute herpetic neuralgia
Endpoint domain: Adverse events/effects
Primary endpoint: positive involvement with their child
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Ischaemic stroke risk
Endpoint domain: Mortality/survival
Primary endpoint: Total carbohydrate oxidation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Peak exogenous carbohydrate oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Endogenous carbohydrate oxidation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean nadir nocturnal glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of patients with glucose levels less than 50 mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of patients with glucose levels less than 60 mg/dl
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Use of asthma medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of patients with at least one adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients spontaneously reporting cough
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of patients discontinuing therapy due to adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Duration of overall breastfeeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean endothelial cell count loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cr-51 radioisotope glomerular filtration rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of biopsy-proven acute rejection episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Composite endpoint of cardiac death, myocardial infarction, and clinically-indicated target vessel revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Clinically-indicated target lesion revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Definite/probable stent thrombosis rate
Endpoint domain: Adverse events/effects
Primary endpoint: Primary composite end point occurrence
Endpoint domain: Mortality/survival
Primary endpoint: In-hospital major bleeding rates
Endpoint domain: Adverse events/effects
Primary endpoint: Peak and integrated EMG in the medial gastrocnemius and soleus
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Peak knee extension power
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: FMI score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5-year cumulative primary end point rate
Endpoint domain: Mortality/survival
Primary endpoint: global impact
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: poor sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Right ventricular (RV) volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Early operative death
Endpoint domain: Mortality/survival
Primary endpoint: Composite of complications
Endpoint domain: Adverse events/effects
Primary endpoint: Loss of proprioception in trunk axial rotation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive decline measured by MMSE
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: False-negative UBT results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Resolution of epigastric pain
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: 12-month cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Muscle cross sectional area (MCSA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of young adults asked about risky drinking
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Risk of post-release homelessness
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Rescue analgesic drug requirement
Endpoint domain: Adverse events/effects
Primary endpoint: health care costs per patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: lengths of stay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient adherence to therapy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: CV mortality due to cardiac arrhythmias
Endpoint domain: Mortality/survival
Primary endpoint: all-cause CV mortality
Endpoint domain: Mortality/survival
Primary endpoint: Passive dorsiflexion with the knee flexed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Tracer enrichment of plasma cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: skeletal muscle mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: skeletal muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: stroke rates
Endpoint domain: Adverse events/effects
Primary endpoint: Agreement on randomized controlled trials as the study design of choice
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: delta DAS28-ESR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Self-Rated Health (SRH) improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Development of CKD
Endpoint domain: Mortality/survival
Primary endpoint: Development of ESRD
Endpoint domain: Mortality/survival
Primary endpoint: amount of urinary incontinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes